Franklin, Parlapiano, Turner & Welch’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Sell
43,284
-1,559
-3% -$363K 2.49% 7
2026
Q1
$10.3M Sell
44,843
-3,306
-7% -$770K 2.46% 8
2025
Q4
$10.5M Sell
48,149
-1,255
-3% -$248K 2.61% 9
2025
Q3
$9.16M Sell
49,404
-1,127
-2% -$193K 2.31% 13
2025
Q2
$7.72M Buy
50,531
+641
+1% +$98.5K 2.02% 17
2025
Q1
$8.27M Buy
49,890
+686
+1% +$107K 2.23% 14
2024
Q4
$7.12M Buy
49,204
+765
+2% +$119K 1.93% 20
2024
Q3
$7.85M Buy
48,439
+548
+1% +$87.3K 2.03% 18
2024
Q2
$7M Buy
47,891
+705
+1% +$105K 1.94% 21
2024
Q1
$7.46M Buy
47,186
+325
+0.7% +$51.7K 2.05% 20
2023
Q4
$7.35M Buy
46,861
+1,113
+2% +$171K 2.11% 20
2023
Q3
$7.13M Buy
45,748
+116
+0.3% +$19.1K 2.21% 19
2023
Q2
$7.55M Buy
45,632
+561
+1% +$90.5K 2.24% 20
2023
Q1
$6.99M Buy
45,071
+371
+0.8% +$59.9K 2.22% 20
2022
Q4
$7.9M Sell
44,700
-417
-0.9% -$72K 2.59% 8
2022
Q3
$7.37M Buy
45,117
+251
+0.6% +$42.5K 2.62% 7
2022
Q2
$7.96M Sell
44,866
-90
-0.2% -$16K 2.69% 5
2022
Q1
$7.97M Buy
44,956
+1,312
+3% +$223K 2.37% 10
2021
Q4
$7.47M Buy
43,644
+1,181
+3% +$193K 2.14% 16
2021
Q3
$6.86M Sell
42,463
-174
-0.4% -$29.7K 2.15% 15
2021
Q2
$7.02M Sell
42,637
-19
-0% -$3.15K 2.17% 15
2021
Q1
$7.01M Buy
42,656
+891
+2% +$144K 2.36% 11
2020
Q4
$6.57M Buy
41,765
+455
+1% +$67.1K 2.38% 10
2020
Q3
$6.15M Sell
41,310
-231
-0.6% -$34.2K 2.48% 11
2020
Q2
$5.84M Sell
41,541
-1,421
-3% -$207K 2.41% 11
2020
Q1
$5.63M Buy
42,962
+462
+1% +$65.5K 2.59% 8
2019
Q4
$6.2M Buy
42,500
+868
+2% +$118K 2.34% 13
2019
Q3
$5.39M Buy
41,632
+1,334
+3% +$176K 2.1% 21
2019
Q2
$5.61M Sell
40,298
-286
-0.7% -$39.6K 2.2% 18
2019
Q1
$5.67M Buy
40,584
+445
+1% +$59.6K 2.24% 16
2018
Q4
$5.18M Buy
40,139
+915
+2% +$128K 2.28% 15
2018
Q3
$5.42M Buy
39,224
+622
+2% +$82.7K 2.16% 15
2018
Q2
$4.68M Buy
38,602
+691
+2% +$86.2K 1.93% 17
2018
Q1
$4.86M Sell
37,911
-476
-1% -$64.3K 2.07% 15
2017
Q4
$5.36M Buy
38,387
+382
+1% +$53.2K 2.2% 13
2017
Q3
$4.94M Buy
38,005
+1,435
+4% +$190K 2.12% 12
2017
Q2
$4.84M Buy
36,570
+148
+0.4% +$18.9K 2.21% 11
2017
Q1
$4.54M Buy
36,422
+1,054
+3% +$126K 2.11% 12
2016
Q4
$4.08M Buy
35,368
+515
+1% +$59.5K 2.02% 15
2016
Q3
$4.12M Buy
34,853
+1,515
+5% +$184K 2.09% 13
2016
Q2
$4.04M Buy
33,338
+2,031
+6% +$231K 2.16% 10
2016
Q1
$3.39M Buy
31,307
+1,493
+5% +$155K 1.87% 21
2015
Q4
$3.06M Buy
29,814
+1,408
+5% +$142K 1.81% 21
2015
Q3
$2.65M Buy
28,406
+215
+0.8% +$20.8K 1.74% 24
2015
Q2
$2.75M Buy
28,191
+337
+1% +$33.7K 1.82% 23
2015
Q1
$2.8M Buy
27,854
+602
+2% +$61.2K 1.88% 22
2014
Q4
$2.85M Buy
27,252
+977
+4% +$103K 1.91% 22
2014
Q3
$2.8M Buy
26,275
+1,054
+4% +$109K 2.01% 13
2014
Q2
$2.64M Buy
25,221
+1,138
+5% +$115K 1.89% 17
2014
Q1
$2.37M Sell
24,083
-1,315
-5% -$122K 1.71% 19
2013
Q4
$2.33M Buy
25,398
+1,431
+6% +$132K 1.61% 20
2013
Q3
$2.08M Buy
23,967
+1,758
+8% +$158K 1.52% 21
2013
Q2
$1.91M Buy
+22,209
New +$1.88M 1.62% 17

Other funds holding JNJ

Franklin, Parlapiano, Turner & Welch's JNJ Position: Q2 2026 in Review

Franklin, Parlapiano, Turner & Welch reduced its Johnson & Johnson (JNJ) stake by 3.5% in Q2 2026, selling an estimated $363K and leaving 43,284 shares worth $11M. The position accounts for 2.49% of the portfolio, ranked #7.

Franklin, Parlapiano, Turner & Welch first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 1,474 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Franklin, Parlapiano, Turner & Welch held 43,284 shares of Johnson & Johnson worth $11M as of Q2 2026.
  • Franklin, Parlapiano, Turner & Welch sold 1,559 Johnson & Johnson shares in Q2 2026, an estimated $363K.
  • Johnson & Johnson made up 2.49% of Franklin, Parlapiano, Turner & Welch's portfolio in Q2 2026, its #7 holding.
  • Franklin, Parlapiano, Turner & Welch first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1,474 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q2 2026, filed 9 Jul 2026.